NFKB1 and ovarian cancer: Importantly, we are the first to demonstrate that TAK1/NF-κB signaling, as the dominant downstream signaling pathway, is similar to mTOR signaling, inversely modulated by AMPK activity, and involved in ovarian cancer aggressiveness in the intraperitoneal cavity or ascites microenvironment.